Post herpetic Neuralgia Treatment Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Post herpetic Neuralgia Treatment market size was valued at USD 1631.9 million in 2022 and is forecast to a readjusted size of USD 2122.8 million by 2029 with a CAGR of 3.8% during review period.

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent. In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.

This report is a detailed and comprehensive analysis for global Post herpetic Neuralgia Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Post herpetic Neuralgia Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Post herpetic Neuralgia Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Post herpetic Neuralgia Treatment market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), 2018-2029
Global Post herpetic Neuralgia Treatment market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Post herpetic Neuralgia Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Post herpetic Neuralgia Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Pfizer
   Arbor Pharma
   Assertio Therapeutics
   Endo Pharma
   Teikoku Pharma
   Teva
   Mylan
   Hengrui Medicine

   Anticonvulsants
   Skin Patch
   Other

   Hospital Pharmacies
   Online Pharmacies
   Retail Pharmacies

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the Post Herpetic Neuralgia Treatment Market in 2025?

The market benefits from growing awareness of the condition, leading to an increase in diagnoses and treatments. Advancements in pharmaceutical treatments and the development of more effective therapies, such as nerve pain inhibitors and transdermal patches, also provide a strong foundation for market growth.

What are the weaknesses of the Post Herpetic Neuralgia Treatment Market in 2025?

Despite advancements, the treatment options are still limited, and many of the available therapies come with side effects, making patient adherence a challenge. Additionally, the high cost of treatment and the complexity of diagnosis can hinder access to care in low-income regions.

What are the opportunities for the Post Herpetic Neuralgia Treatment Market in 2025?

There is significant potential for the development of novel therapies, including biologics and personalized medicine, which could offer improved pain management. Expanding market access in emerging economies and further research into combining therapies offers new opportunities for growth.

What are the threats to the Post Herpetic Neuralgia Treatment Market in 2025?

The market faces the threat of competition from generic drugs, which may drive down prices and affect revenue for branded treatments. The ongoing challenge of accurately diagnosing post herpetic neuralgia and the impact of regulatory hurdles on the approval of new treatments could also limit market growth.

What are the political factors influencing the Post Herpetic Neuralgia Treatment Market in 2025?

Government healthcare policies and reimbursement rates play a significant role in determining the accessibility and affordability of treatments. Policies encouraging research funding for neuropathic pain therapies can also positively impact market growth.

What are the economic factors affecting the Post Herpetic Neuralgia Treatment Market in 2025?

The rising costs of healthcare, including prescription drugs and hospital treatments, can limit access to post herpetic neuralgia therapies. However, economic growth in emerging markets may increase patient access to advanced treatments, offering growth opportunities in these regions.

What are the social factors impacting the Post Herpetic Neuralgia Treatment Market in 2025?

An aging population and increasing awareness about the long-term effects of shingles drive the demand for treatments. Additionally, changing patient attitudes towards alternative therapies, such as natural or non-invasive treatments, may influence the adoption of conventional medications.

What are the technological factors affecting the Post Herpetic Neuralgia Treatment Market in 2025?

Advances in medical technology, such as new diagnostic tools for post herpetic neuralgia and innovations in drug delivery systems, are enhancing the efficacy of treatments. The growing trend of telemedicine also offers more accessible treatment options for patients in remote areas.

What are the environmental factors influencing the Post Herpetic Neuralgia Treatment Market in 2025?

Environmental factors such as climate change may influence the prevalence of shingles outbreaks, affecting the incidence of post herpetic neuralgia. Moreover, sustainability concerns in the pharmaceutical industry, particularly regarding packaging and production methods, could drive demand for eco-friendly solutions.

What are the legal factors affecting the Post Herpetic Neuralgia Treatment Market in 2025?

Regulations surrounding the approval of new drugs and treatments, as well as intellectual property rights, can impact the speed at which new therapies reach the market. Additionally, legal challenges related to patent expirations and generic drug competition could influence market dynamics.

Who are the suppliers in the Post Herpetic Neuralgia Treatment Market in 2025?

Suppliers include pharmaceutical companies, biotechnology firms, research institutions, and manufacturers of medical devices that specialize in pain management and transdermal patches.

What inputs are needed for the Post Herpetic Neuralgia Treatment Market in 2025?

Key inputs involve raw materials for drug production, research and development data, clinical trial results, regulatory approvals, and skilled healthcare professionals for diagnosis and treatment management.

Who are the process owners in the Post Herpetic Neuralgia Treatment Market in 2025?

Process owners include pharmaceutical companies developing drugs, healthcare providers prescribing treatments, and research organizations focusing on the advancement of neuropathic pain management.

What are the outputs in the Post Herpetic Neuralgia Treatment Market in 2025?

Outputs include approved pharmaceutical treatments, pain management devices, clinical guidelines, and post-treatment care protocols. Additionally, patient outcomes and satisfaction are also key outputs of the treatment process.

Who are the customers in the Post Herpetic Neuralgia Treatment Market in 2025?

Customers consist of patients suffering from post herpetic neuralgia, healthcare providers, hospitals, and insurance companies that manage reimbursements for treatment costs.

What is the threat of new entrants in the Post Herpetic Neuralgia Treatment Market in 2025?

The threat of new entrants is moderate. While the market holds potential due to the demand for effective treatments, the high cost of R&D, regulatory hurdles, and the need for significant expertise in neurological pain management act as barriers to entry.

What is the bargaining power of suppliers in the Post Herpetic Neuralgia Treatment Market in 2025?

The bargaining power of suppliers is moderate. Pharmaceutical companies and medical device manufacturers have significant control over the production of treatments, but the large number of suppliers and the increasing focus on generic alternatives gives buyers some negotiating power.

What is the bargaining power of buyers in the Post Herpetic Neuralgia Treatment Market in 2025?

The bargaining power of buyers is relatively high, especially in developed markets with access to multiple treatment options. However, in emerging markets, limited access to healthcare resources can reduce buyers’ negotiating power, leaving them more dependent on available treatments.

What is the threat of substitute products in the Post Herpetic Neuralgia Treatment Market in 2025?

The threat of substitutes is moderate. While traditional pharmaceutical treatments dominate, alternative therapies, such as acupuncture, physical therapy, and natural remedies, are gaining popularity. However, these alternatives may not offer the same level of efficacy, keeping pharmaceutical treatments at the forefront.

What is the intensity of competitive rivalry in the Post Herpetic Neuralgia Treatment Market in 2025?

The competitive rivalry is high. With several pharmaceutical companies competing to develop the most effective treatments, the market is crowded with various medications and devices. Additionally, the growth of generic alternatives intensifies competition, especially as patents for branded drugs expire.

What are the key inputs for the Post Herpetic Neuralgia Treatment Market in 2025?

Key inputs include raw materials for drug production, advanced medical technologies, clinical trial data, and skilled healthcare professionals for proper diagnosis and treatment administration. Additionally, regulatory approvals and market research are critical inputs.

What are the main suppliers for the Post Herpetic Neuralgia Treatment Market in 2025?

Suppliers include pharmaceutical companies producing pain relief drugs, biotechnology firms working on innovative treatments, and manufacturers of medical devices like transdermal patches. Research institutions also play a role by providing data and insights into treatment efficacy.

What are the key challenges in the upstream supply chain of the Post Herpetic Neuralgia Treatment Market in 2025?

Challenges include high R&D costs, the complexity of obtaining regulatory approvals, and the dependence on skilled labor for both research and clinical applications. Supply chain disruptions due to raw material shortages or regulatory changes could also hinder market growth.

What technological factors are impacting the upstream in the Post Herpetic Neuralgia Treatment Market in 2025?

Advancements in drug delivery systems, such as transdermal patches and injectable treatments, are key technological factors. Research into new drug formulations and personalized medicine approaches also impacts the upstream by driving demand for innovative treatment options.

What regulatory factors affect the upstream in the Post Herpetic Neuralgia Treatment Market in 2025?

Regulatory approvals are a significant factor. The lengthy process of getting new treatments approved by agencies such as the FDA or EMA can delay product availability. Additionally, adherence to safety and quality standards in drug production and medical device manufacturing is essential for market success.

What are the key activities in the midstream of the Post Herpetic Neuralgia Treatment Market in 2025?

Key activities include the manufacturing of drugs and medical devices, clinical trials to assess the efficacy and safety of new treatments, and partnerships between pharmaceutical companies and healthcare providers to ensure effective distribution of therapies.

What are the main players involved in the midstream of the Post Herpetic Neuralgia Treatment Market in 2025?

Main players include pharmaceutical companies responsible for developing and manufacturing treatments, contract research organizations (CROs) conducting clinical trials, and distribution partners ensuring access to healthcare facilities. Hospitals and pain management clinics also play a significant role in administering treatments.

What are the challenges in the midstream of the Post Herpetic Neuralgia Treatment Market in 2025?

Challenges include ensuring the quality and consistency of treatment production, managing the costs of clinical trials, and overcoming regulatory hurdles. Additionally, there are issues with distribution logistics, particularly in remote or underserved regions, which can limit patient access to effective treatments.

What technological factors are influencing the midstream in the Post Herpetic Neuralgia Treatment Market in 2025?

Technological advancements such as automated manufacturing processes, improved drug delivery systems, and the development of personalized medicine are influencing the midstream. Innovations in diagnostic tools and treatment administration methods also enhance the overall effectiveness of post herpetic neuralgia management.

What role do partnerships play in the midstream of the Post Herpetic Neuralgia Treatment Market in 2025?

Partnerships between pharmaceutical companies, research institutions, and healthcare providers are crucial for clinical trials, product development, and treatment distribution. Collaborations help accelerate innovation, improve treatment access, and ensure the successful launch of new therapies.

What are the key activities in the downstream of the Post Herpetic Neuralgia Treatment Market in 2025?

Key activities in the downstream include patient diagnosis, treatment administration by healthcare professionals, ongoing management of symptoms, and post-treatment care. Distribution of treatments through hospitals, clinics, and pharmacies also plays a crucial role in ensuring accessibility.

Who are the main stakeholders in the downstream of the Post Herpetic Neuralgia Treatment Market in 2025?

Main stakeholders include healthcare providers (such as pain specialists and neurologists), hospitals, pharmacies, insurance companies, and patients. Pharmaceutical companies and medical device manufacturers are also indirectly involved by ensuring the availability of treatments.

What are the challenges in the downstream of the Post Herpetic Neuralgia Treatment Market in 2025?

Challenges include limited access to specialized healthcare providers, especially in underserved regions. High treatment costs and patient adherence to prescribed therapies are also significant barriers. Additionally, insurance coverage and reimbursement issues can hinder patients from receiving the necessary treatments.

What technological factors are influencing the downstream in the Post Herpetic Neuralgia Treatment Market in 2025?

Technological advancements in telemedicine and digital health tools are influencing the downstream by making consultations and follow-up care more accessible. New methods of pain management, such as wearable devices for real-time pain monitoring and control, are also enhancing patient care.

What role does patient education play in the downstream of the Post Herpetic Neuralgia Treatment Market in 2025?

Patient education is critical in improving treatment outcomes. Educating patients about the nature of the condition, the importance of adherence to prescribed therapies, and the management of pain can enhance their overall experience and increase the effectiveness of treatments.

Chapter 1, to describe Post herpetic Neuralgia Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Post herpetic Neuralgia Treatment, with revenue, gross margin and global market share of Post herpetic Neuralgia Treatment from 2018 to 2023.
Chapter 3, the Post herpetic Neuralgia Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Post herpetic Neuralgia Treatment market forecast, by regions, type and distribution channel, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Post herpetic Neuralgia Treatment.
Chapter 13, to describe Post herpetic Neuralgia Treatment research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Post herpetic Neuralgia Treatment
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Post herpetic Neuralgia Treatment by Type
       1.3.1 Overview: Global Post herpetic Neuralgia Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Post herpetic Neuralgia Treatment Consumption Value Market Share by Type in 2022
       1.3.3 Anticonvulsants
       1.3.4 Skin Patch
       1.3.5 Other
   1.4 Global Post herpetic Neuralgia Treatment Market by Distribution Channel
       1.4.1 Overview: Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel: 2018 Versus 2022 Versus 2029
       1.4.2 Hospital Pharmacies
       1.4.3 Online Pharmacies
       1.4.4 Retail Pharmacies
   1.5 Global Post herpetic Neuralgia Treatment Market Size & Forecast
   1.6 Global Post herpetic Neuralgia Treatment Market Size and Forecast by Region
       1.6.1 Global Post herpetic Neuralgia Treatment Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Post herpetic Neuralgia Treatment Market Size by Region, (2018-2029)
       1.6.3 North America Post herpetic Neuralgia Treatment Market Size and Prospect (2018-2029)
       1.6.4 Europe Post herpetic Neuralgia Treatment Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Post herpetic Neuralgia Treatment Market Size and Prospect (2018-2029)
       1.6.6 South America Post herpetic Neuralgia Treatment Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Post herpetic Neuralgia Treatment Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Pfizer
       2.1.1 Pfizer Details
       2.1.2 Pfizer Major Business
       2.1.3 Pfizer Post herpetic Neuralgia Treatment Product and Solutions
       2.1.4 Pfizer Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Pfizer Recent Developments and Future Plans
   2.2 Arbor Pharma
       2.2.1 Arbor Pharma Details
       2.2.2 Arbor Pharma Major Business
       2.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Product and Solutions
       2.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Arbor Pharma Recent Developments and Future Plans
   2.3 Assertio Therapeutics
       2.3.1 Assertio Therapeutics Details
       2.3.2 Assertio Therapeutics Major Business
       2.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Product and Solutions
       2.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Assertio Therapeutics Recent Developments and Future Plans
   2.4 Endo Pharma
       2.4.1 Endo Pharma Details
       2.4.2 Endo Pharma Major Business
       2.4.3 Endo Pharma Post herpetic Neuralgia Treatment Product and Solutions
       2.4.4 Endo Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Endo Pharma Recent Developments and Future Plans
   2.5 Teikoku Pharma
       2.5.1 Teikoku Pharma Details
       2.5.2 Teikoku Pharma Major Business
       2.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Product and Solutions
       2.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Teikoku Pharma Recent Developments and Future Plans
   2.6 Teva
       2.6.1 Teva Details
       2.6.2 Teva Major Business
       2.6.3 Teva Post herpetic Neuralgia Treatment Product and Solutions
       2.6.4 Teva Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Teva Recent Developments and Future Plans
   2.7 Mylan
       2.7.1 Mylan Details
       2.7.2 Mylan Major Business
       2.7.3 Mylan Post herpetic Neuralgia Treatment Product and Solutions
       2.7.4 Mylan Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Mylan Recent Developments and Future Plans
   2.8 Hengrui Medicine
       2.8.1 Hengrui Medicine Details
       2.8.2 Hengrui Medicine Major Business
       2.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Product and Solutions
       2.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Hengrui Medicine Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Post herpetic Neuralgia Treatment Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Post herpetic Neuralgia Treatment by Company Revenue
       3.2.2 Top 3 Post herpetic Neuralgia Treatment Players Market Share in 2022
       3.2.3 Top 6 Post herpetic Neuralgia Treatment Players Market Share in 2022
   3.3 Post herpetic Neuralgia Treatment Market: Overall Company Footprint Analysis
       3.3.1 Post herpetic Neuralgia Treatment Market: Region Footprint
       3.3.2 Post herpetic Neuralgia Treatment Market: Company Product Type Footprint
       3.3.3 Post herpetic Neuralgia Treatment Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Post herpetic Neuralgia Treatment Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Post herpetic Neuralgia Treatment Market Forecast by Type (2024-2029)

5 Market Size Segment by Distribution Channel

   5.1 Global Post herpetic Neuralgia Treatment Consumption Value Market Share by Distribution Channel (2018-2023)
   5.2 Global Post herpetic Neuralgia Treatment Market Forecast by Distribution Channel (2024-2029)

6 North America

   6.1 North America Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2029)
   6.2 North America Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2029)
   6.3 North America Post herpetic Neuralgia Treatment Market Size by Country
       6.3.1 North America Post herpetic Neuralgia Treatment Consumption Value by Country (2018-2029)
       6.3.2 United States Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       6.3.3 Canada Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       6.3.4 Mexico Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2029)
   7.2 Europe Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2029)
   7.3 Europe Post herpetic Neuralgia Treatment Market Size by Country
       7.3.1 Europe Post herpetic Neuralgia Treatment Consumption Value by Country (2018-2029)
       7.3.2 Germany Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       7.3.3 France Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       7.3.5 Russia Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       7.3.6 Italy Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2029)
   8.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region
       8.3.1 Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Region (2018-2029)
       8.3.2 China Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       8.3.3 Japan Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       8.3.4 South Korea Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       8.3.5 India Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       8.3.7 Australia Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2029)
   9.2 South America Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2029)
   9.3 South America Post herpetic Neuralgia Treatment Market Size by Country
       9.3.1 South America Post herpetic Neuralgia Treatment Consumption Value by Country (2018-2029)
       9.3.2 Brazil Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       9.3.3 Argentina Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2029)
   10.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country
       10.3.1 Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Country (2018-2029)
       10.3.2 Turkey Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)
       10.3.4 UAE Post herpetic Neuralgia Treatment Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Post herpetic Neuralgia Treatment Market Drivers
   11.2 Post herpetic Neuralgia Treatment Market Restraints
   11.3 Post herpetic Neuralgia Treatment Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Post herpetic Neuralgia Treatment Industry Chain
   12.2 Post herpetic Neuralgia Treatment Upstream Analysis
   12.3 Post herpetic Neuralgia Treatment Midstream Analysis
   12.4 Post herpetic Neuralgia Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Post herpetic Neuralgia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Post herpetic Neuralgia Treatment Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Post herpetic Neuralgia Treatment Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Pfizer Company Information, Head Office, and Major Competitors
   Table 6. Pfizer Major Business
   Table 7. Pfizer Post herpetic Neuralgia Treatment Product and Solutions
   Table 8. Pfizer Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Pfizer Recent Developments and Future Plans
   Table 10. Arbor Pharma Company Information, Head Office, and Major Competitors
   Table 11. Arbor Pharma Major Business
   Table 12. Arbor Pharma Post herpetic Neuralgia Treatment Product and Solutions
   Table 13. Arbor Pharma Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Arbor Pharma Recent Developments and Future Plans
   Table 15. Assertio Therapeutics Company Information, Head Office, and Major Competitors
   Table 16. Assertio Therapeutics Major Business
   Table 17. Assertio Therapeutics Post herpetic Neuralgia Treatment Product and Solutions
   Table 18. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Assertio Therapeutics Recent Developments and Future Plans
   Table 20. Endo Pharma Company Information, Head Office, and Major Competitors
   Table 21. Endo Pharma Major Business
   Table 22. Endo Pharma Post herpetic Neuralgia Treatment Product and Solutions
   Table 23. Endo Pharma Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Endo Pharma Recent Developments and Future Plans
   Table 25. Teikoku Pharma Company Information, Head Office, and Major Competitors
   Table 26. Teikoku Pharma Major Business
   Table 27. Teikoku Pharma Post herpetic Neuralgia Treatment Product and Solutions
   Table 28. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Teikoku Pharma Recent Developments and Future Plans
   Table 30. Teva Company Information, Head Office, and Major Competitors
   Table 31. Teva Major Business
   Table 32. Teva Post herpetic Neuralgia Treatment Product and Solutions
   Table 33. Teva Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Teva Recent Developments and Future Plans
   Table 35. Mylan Company Information, Head Office, and Major Competitors
   Table 36. Mylan Major Business
   Table 37. Mylan Post herpetic Neuralgia Treatment Product and Solutions
   Table 38. Mylan Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Mylan Recent Developments and Future Plans
   Table 40. Hengrui Medicine Company Information, Head Office, and Major Competitors
   Table 41. Hengrui Medicine Major Business
   Table 42. Hengrui Medicine Post herpetic Neuralgia Treatment Product and Solutions
   Table 43. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Hengrui Medicine Recent Developments and Future Plans
   Table 45. Global Post herpetic Neuralgia Treatment Revenue (USD Million) by Players (2018-2023)
   Table 46. Global Post herpetic Neuralgia Treatment Revenue Share by Players (2018-2023)
   Table 47. Breakdown of Post herpetic Neuralgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 48. Market Position of Players in Post herpetic Neuralgia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 49. Head Office of Key Post herpetic Neuralgia Treatment Players
   Table 50. Post herpetic Neuralgia Treatment Market: Company Product Type Footprint
   Table 51. Post herpetic Neuralgia Treatment Market: Company Product Application Footprint
   Table 52. Post herpetic Neuralgia Treatment New Market Entrants and Barriers to Market Entry
   Table 53. Post herpetic Neuralgia Treatment Mergers, Acquisition, Agreements, and Collaborations
   Table 54. Global Post herpetic Neuralgia Treatment Consumption Value (USD Million) by Type (2018-2023)
   Table 55. Global Post herpetic Neuralgia Treatment Consumption Value Share by Type (2018-2023)
   Table 56. Global Post herpetic Neuralgia Treatment Consumption Value Forecast by Type (2024-2029)
   Table 57. Global Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2023)
   Table 58. Global Post herpetic Neuralgia Treatment Consumption Value Forecast by Distribution Channel (2024-2029)
   Table 59. North America Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2023) & (USD Million)
   Table 60. North America Post herpetic Neuralgia Treatment Consumption Value by Type (2024-2029) & (USD Million)
   Table 61. North America Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2023) & (USD Million)
   Table 62. North America Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2024-2029) & (USD Million)
   Table 63. North America Post herpetic Neuralgia Treatment Consumption Value by Country (2018-2023) & (USD Million)
   Table 64. North America Post herpetic Neuralgia Treatment Consumption Value by Country (2024-2029) & (USD Million)
   Table 65. Europe Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2023) & (USD Million)
   Table 66. Europe Post herpetic Neuralgia Treatment Consumption Value by Type (2024-2029) & (USD Million)
   Table 67. Europe Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2023) & (USD Million)
   Table 68. Europe Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2024-2029) & (USD Million)
   Table 69. Europe Post herpetic Neuralgia Treatment Consumption Value by Country (2018-2023) & (USD Million)
   Table 70. Europe Post herpetic Neuralgia Treatment Consumption Value by Country (2024-2029) & (USD Million)
   Table 71. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2023) & (USD Million)
   Table 72. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Type (2024-2029) & (USD Million)
   Table 73. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2023) & (USD Million)
   Table 74. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2024-2029) & (USD Million)
   Table 75. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Region (2018-2023) & (USD Million)
   Table 76. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Region (2024-2029) & (USD Million)
   Table 77. South America Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2023) & (USD Million)
   Table 78. South America Post herpetic Neuralgia Treatment Consumption Value by Type (2024-2029) & (USD Million)
   Table 79. South America Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2023) & (USD Million)
   Table 80. South America Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2024-2029) & (USD Million)
   Table 81. South America Post herpetic Neuralgia Treatment Consumption Value by Country (2018-2023) & (USD Million)
   Table 82. South America Post herpetic Neuralgia Treatment Consumption Value by Country (2024-2029) & (USD Million)
   Table 83. Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Type (2018-2023) & (USD Million)
   Table 84. Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Type (2024-2029) & (USD Million)
   Table 85. Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2018-2023) & (USD Million)
   Table 86. Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2024-2029) & (USD Million)
   Table 87. Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Country (2018-2023) & (USD Million)
   Table 88. Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Country (2024-2029) & (USD Million)
   Table 89. Post herpetic Neuralgia Treatment Raw Material
   Table 90. Key Suppliers of Post herpetic Neuralgia Treatment Raw Materials

List of Figures

   Figure 1. Post herpetic Neuralgia Treatment Picture
   Figure 2. Global Post herpetic Neuralgia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Post herpetic Neuralgia Treatment Consumption Value Market Share by Type in 2022
   Figure 4. Anticonvulsants
   Figure 5. Skin Patch
   Figure 6. Other
   Figure 7. Global Post herpetic Neuralgia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 8. Post herpetic Neuralgia Treatment Consumption Value Market Share by Distribution Channel in 2022
   Figure 9. Hospital Pharmacies Picture
   Figure 10. Online Pharmacies Picture
   Figure 11. Retail Pharmacies Picture
   Figure 12. Global Post herpetic Neuralgia Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Post herpetic Neuralgia Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Market Post herpetic Neuralgia Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 15. Global Post herpetic Neuralgia Treatment Consumption Value Market Share by Region (2018-2029)
   Figure 16. Global Post herpetic Neuralgia Treatment Consumption Value Market Share by Region in 2022
   Figure 17. North America Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 18. Europe Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 19. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 20. South America Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 21. Middle East and Africa Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 22. Global Post herpetic Neuralgia Treatment Revenue Share by Players in 2022
   Figure 23. Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 24. Global Top 3 Players Post herpetic Neuralgia Treatment Market Share in 2022
   Figure 25. Global Top 6 Players Post herpetic Neuralgia Treatment Market Share in 2022
   Figure 26. Global Post herpetic Neuralgia Treatment Consumption Value Share by Type (2018-2023)
   Figure 27. Global Post herpetic Neuralgia Treatment Market Share Forecast by Type (2024-2029)
   Figure 28. Global Post herpetic Neuralgia Treatment Consumption Value Share by Distribution Channel (2018-2023)
   Figure 29. Global Post herpetic Neuralgia Treatment Market Share Forecast by Distribution Channel (2024-2029)
   Figure 30. North America Post herpetic Neuralgia Treatment Consumption Value Market Share by Type (2018-2029)
   Figure 31. North America Post herpetic Neuralgia Treatment Consumption Value Market Share by Distribution Channel (2018-2029)
   Figure 32. North America Post herpetic Neuralgia Treatment Consumption Value Market Share by Country (2018-2029)
   Figure 33. United States Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 34. Canada Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 35. Mexico Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 36. Europe Post herpetic Neuralgia Treatment Consumption Value Market Share by Type (2018-2029)
   Figure 37. Europe Post herpetic Neuralgia Treatment Consumption Value Market Share by Distribution Channel (2018-2029)
   Figure 38. Europe Post herpetic Neuralgia Treatment Consumption Value Market Share by Country (2018-2029)
   Figure 39. Germany Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 40. France Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 41. United Kingdom Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 42. Russia Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 43. Italy Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 44. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value Market Share by Type (2018-2029)
   Figure 45. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value Market Share by Distribution Channel (2018-2029)
   Figure 46. Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value Market Share by Region (2018-2029)
   Figure 47. China Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 48. Japan Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 49. South Korea Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 50. India Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 51. Southeast Asia Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 52. Australia Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 53. South America Post herpetic Neuralgia Treatment Consumption Value Market Share by Type (2018-2029)
   Figure 54. South America Post herpetic Neuralgia Treatment Consumption Value Market Share by Distribution Channel (2018-2029)
   Figure 55. South America Post herpetic Neuralgia Treatment Consumption Value Market Share by Country (2018-2029)
   Figure 56. Brazil Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 57. Argentina Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 58. Middle East and Africa Post herpetic Neuralgia Treatment Consumption Value Market Share by Type (2018-2029)
   Figure 59. Middle East and Africa Post herpetic Neuralgia Treatment Consumption Value Market Share by Distribution Channel (2018-2029)
   Figure 60. Middle East and Africa Post herpetic Neuralgia Treatment Consumption Value Market Share by Country (2018-2029)
   Figure 61. Turkey Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 62. Saudi Arabia Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 63. UAE Post herpetic Neuralgia Treatment Consumption Value (2018-2029) & (USD Million)
   Figure 64. Post herpetic Neuralgia Treatment Market Drivers
   Figure 65. Post herpetic Neuralgia Treatment Market Restraints
   Figure 66. Post herpetic Neuralgia Treatment Market Trends
   Figure 67. Porters Five Forces Analysis
   Figure 68. Manufacturing Cost Structure Analysis of Post herpetic Neuralgia Treatment in 2022
   Figure 69. Manufacturing Process Analysis of Post herpetic Neuralgia Treatment
   Figure 70. Post herpetic Neuralgia Treatment Industrial Chain
   Figure 71. Methodology
   Figure 72. Research Process and Data Source